Treatment of American dermal leishmaniasis with a special oral dosage form of tartar emetic.
D000965:Antimony / Q000627:therapeutic use*; D000966:Antimony Potassium Tartrate; D006801:Humans; D007896:Leishmaniasis; D016773:Leishmaniasis, Cutaneous; D007897:Leishmaniasis, Mucocutaneous / Q000628:therapy*; D013386:Succinates / Q000627:therapeutic use*; D014481:United States
D013386:Succinates; D000965:Antimony; D000966:Antimony Potassium Tartrate
ANTIMONY/therapeutic use; LEISHMANIASIS, MUCOCUTANEOUS/therapy; SUCCINATES/therapeutic use